Odyssey Group International, Inc. (ODYY)
OTCMKTS: ODYY · Delayed Price · USD
0.0400
0.00 (0.00%)
Jul 2, 2024, 3:36 PM EDT - Market closed
Company Description
Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products.
It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders.
The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
Odyssey Group International, Inc.
| Country | NV |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Ms. Christine M. Farrell |
Contact Details
Address: 2300 West Sahara Avenue, Suite 800-#4012 Las Vegas, Nevada 89102 United States | |
| Phone | 702-780-6559 |
| Website | odysseyhealthinc.com |
Stock Details
| Ticker Symbol | ODYY |
| Exchange | OTCMKTS |
| Fiscal Year | August - July |
| Reporting Currency | USD |
| CIK Code | 0001626644 |
| CUSIP Number | 67612C102 |
| ISIN Number | US67612C1027 |
| Employer ID | 47-1022125 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Christine M. Farrell | Chief Financial Officer, Controller and Secretary |
| Michael Contarino | Head of Product Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 14, 2024 | 10-Q | Quarterly Report |
| Mar 22, 2024 | 10-Q | Quarterly Report |
| Mar 18, 2024 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Jan 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jan 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jan 5, 2024 | 8-K | Current Report |
| Jan 5, 2024 | 8-A12G | Filing |
| Dec 29, 2023 | 8-K | Current Report |
| Dec 15, 2023 | 10-Q | Quarterly Report |
| Dec 13, 2023 | 8-K | Current Report |